Mary P. Carroll

2.8k total citations
39 papers, 1.8k citations indexed

About

Mary P. Carroll is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Mary P. Carroll has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Mary P. Carroll's work include Cystic Fibrosis Research Advances (27 papers), Gut microbiota and health (16 papers) and Respiratory viral infections research (7 papers). Mary P. Carroll is often cited by papers focused on Cystic Fibrosis Research Advances (27 papers), Gut microbiota and health (16 papers) and Respiratory viral infections research (7 papers). Mary P. Carroll collaborates with scholars based in United Kingdom, Australia and United States. Mary P. Carroll's co-authors include Kenneth D. Bruce, Geraint B. Rogers, T. Daniels, Franziska A. Stressmann, Lucas R. Hoffman, Chris Gast, Alan W. Walker, Julian Parkhill, Valia Kehagia and Janis K. Shute and has published in prestigious journals such as PLoS ONE, Journal of Applied Physiology and Journal of Clinical Microbiology.

In The Last Decade

Mary P. Carroll

39 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary P. Carroll United Kingdom	24	1.1k	842	318	292	259	39	1.8k
Edith T. Zemanick United States	24	1.8k 1.6×	807 1.0×	187 0.6×	339 1.2×	260 1.0×	79	2.4k
David J. Serisier Australia	20	1.6k 1.5×	544 0.6×	233 0.7×	544 1.9×	349 1.3×	49	2.1k
Marc A. Sze United States	16	587 0.5×	1.2k 1.5×	431 1.4×	256 0.9×	351 1.4×	25	2.0k
R. Chiron France	26	1.5k 1.4×	365 0.4×	362 1.1×	347 1.2×	87 0.3×	93	2.1k
Lisa McCloskey United States	13	879 0.8×	992 1.2×	372 1.2×	374 1.3×	520 2.0×	16	1.9k
Paúl Cárdenas Ecuador	13	616 0.6×	947 1.1×	607 1.9×	299 1.0×	489 1.9×	48	2.0k
Ayannah S. Fitzgerald United States	7	417 0.4×	685 0.8×	162 0.5×	320 1.1×	271 1.0×	11	1.3k
Aimee L. Brauer United States	21	620 0.6×	387 0.5×	151 0.5×	841 2.9×	182 0.7×	39	1.7k
Benjamin G. Wu United States	18	515 0.5×	1.1k 1.3×	231 0.7×	379 1.3×	366 1.4×	42	1.8k
Alexa A. Pragman United States	17	597 0.5×	672 0.8×	158 0.5×	224 0.8×	244 0.9×	29	1.4k

Countries citing papers authored by Mary P. Carroll

Since Specialization

Citations

This map shows the geographic impact of Mary P. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary P. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary P. Carroll more than expected).

Fields of papers citing papers by Mary P. Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary P. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary P. Carroll. The network helps show where Mary P. Carroll may publish in the future.

Co-authorship network of co-authors of Mary P. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Mary P. Carroll. A scholar is included among the top collaborators of Mary P. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary P. Carroll. Mary P. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wing, Peter A. C., et al.. (2025). Interplay between respiratory viruses and cilia in the airways. European Respiratory Review. 34(175). 240224–240224. 2 indexed citations

Shute, Janis K., Michael H. Cummings, Anthony I. Shepherd, et al.. (2020). Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis. Redox Biology. 32. 101436–101436. 36 indexed citations

Shute, Janis K., Michael H. Cummings, Anthony I. Shepherd, et al.. (2019). The implications of dysglycaemia on aerobic exercise and ventilatory function in cystic fibrosis. Journal of Cystic Fibrosis. 19(3). 427–433. 7 indexed citations

Corrales‐Medina, Fernando F., James M. Stark, S. Shahrukh Hashmi, et al.. (2015). Application of an Asthma Screening Questionnaire in Children with Sickle Cell Disease. Pediatric Allergy Immunology and Pulmonology. 28(3). 177–182. 8 indexed citations

Rogers, Geraint B., Dominick Shaw, Robyn L. Marsh, et al.. (2015). Republished: Respiratory microbiota: addressing clinical questions, informing clinical practice. Postgraduate Medical Journal. 91(1078). 463–470. 1 indexed citations

Lucas, Jane S., Laura Behan, Audrey Dunn Galvin, et al.. (2015). A quality-of-life measure for adults with primary ciliary dyskinesia: QOL–PCD. European Respiratory Journal. 46(2). 375–383. 43 indexed citations

Grainge, Christopher, Geraint B. Rogers, Valia Kehagia, et al.. (2014). Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe Asthma. PLoS ONE. 9(6). e100645–e100645. 242 indexed citations

Cuthbertson, Leah, Geraint B. Rogers, Alan W. Walker, et al.. (2014). Implications of multiple freeze-thawing on respiratory samples for culture-independent analyses. Journal of Cystic Fibrosis. 14(4). 464–467. 27 indexed citations

Kozłowska, Justyna, Damian Rivett, Louic S. Vermeer, et al.. (2013). A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation. Metabolomics. 9(6). 1262–1273. 16 indexed citations

10.

Stressmann, Franziska A., Geraint B. Rogers, Peter Marsh, et al.. (2011). Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?. Journal of Cystic Fibrosis. 10(5). 357–365. 102 indexed citations

11.

Rogers, Geraint B., Lucas R. Hoffman, Matt Johnson, et al.. (2011). Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset. Expert Review of Molecular Diagnostics. 11(2). 197–206. 15 indexed citations

12.

Rogers, Geraint B., Mary P. Carroll, Franziska A. Stressmann, et al.. (2010). Symposium Summaries. Pediatric Pulmonology. 45(S33). 107–219. 1 indexed citations

13.

Rogers, Geraint B., Lucas R. Hoffman, Marvin Whiteley, et al.. (2010). Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends in Microbiology. 18(8). 357–364. 59 indexed citations

14.

Rogers, Geraint B., Franziska A. Stressmann, Alan W. Walker, Mary P. Carroll, & Kenneth D. Bruce. (2010). Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity. Expert Review of Molecular Diagnostics. 10(2). 187–196. 31 indexed citations

15.

Rogers, Geraint B., Mary P. Carroll, & Kenneth D. Bruce. (2009). Studying bacterial infections through culture-independent approaches. Journal of Medical Microbiology. 58(11). 1401–1418. 63 indexed citations

16.

Carroll, Mary P., et al.. (2009). Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients. Diagnostic Microbiology and Infectious Disease. 63(3). 261–267. 4 indexed citations

17.

Rogers, Geraint B., Franziska A. Stressmann, Garrit Koller, et al.. (2008). Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. Diagnostic Microbiology and Infectious Disease. 62(2). 133–141. 68 indexed citations

18.

Broughton-Head, Victoria J., Jagdeep Shur, Mary P. Carroll, James R. Smith, & Janis K. Shute. (2007). Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 293(5). L1240–L1249. 44 indexed citations

19.

Serisier, David J., Graeme Jones, Andrew Tuck, Gary Connett, & Mary P. Carroll. (2003). Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosis. Pediatric Pulmonology. 35(6). 463–466. 5 indexed citations

20.

Mulvey, David A., Mark W. Elliott, Νikolaos Koulouris, et al.. (1991). Sniff Esophageal and Nasopharyngeal Pressures and Maximal Relaxation Rates in Patients with Respiratory Dysfunction. American Review of Respiratory Disease. 143(5_pt_1). 950–953. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact